Pfizer is buying sickle cell drug maker Global Blood Therapeutics in an approximately $5.4 billion deal as it looks to accelerate growth after its revenue soared during the pandemic
Related posts
-
Villa Park police warn people to stay away from North Avenue
In the wake of a high-speed collision and a takeover in the area, Villa Park police... -
Palatine says farewell to man who helped village chart debt-free path
Palatine said goodbye this month to Finance Director Paul Mehring, who retired Friday after 28 years... -
Bears lose ninth straight: What worked, what didn’t?
What worked and what didn’t for the Bears in Sunday’s 34-17 loss to the Lions?